Cancer Drug News More men with advanced prostate cancer could be successfully treated with precision drug olaparib
Protected: Tecartus® (Brexucabtagene Autoleucel) CAR T-cell therapy now funded in Australia for adult relapsed or refractory B-cell precursor acute lymphoblastic leukaemia (r/r ALL)
Protected: Tecartus® (Brexucabtagene Autoleucel) CAR T-cell therapy now funded in Australia for the treatment of relapsed or refractory mantle cell lymphoma (r/r MCL)
Cancer Drug News FDA grants accelerated approval to linvoseltamab-gcpt for relapsed or refractory multiple myeloma July 9, 2025 On July 2, 2025, the Food and Drug Administration granted accelerated approval to linvoseltamab-gcpt, a…
Cancer Drug News FDA grants accelerated approval to sunvozertinib for metastatic non-small cell lung cancer with EGFR exon 20 insertion mutations July 9, 2025 On July 2, 2025, the Food and Drug Administration granted accelerated approval to sunvozertinib Pharmaceutical…
Cancer Drug News FDA approves tafasitamab-cxix for relapsed or refractory follicular lymphoma June 30, 2025 On June 18, 2025, the Food and Drug Administration approved tafasitamab-cxix with lenalidomide and rituximab…
Cancer Drug News Fixed-duration acalabrutinib-based regimens approved in EU for patients with chronic lymphocytic leukaemia in the 1st-line setting June 25, 2025 A fixed-duration regimen of acalabrutinib in combination with venetoclax, with or without obinutuzumab, has been…
Cancer Drug News Thousands of blood cancer patients could benefit from new drug combination June 24, 2025 Thousands of patients with a common type of blood cancer could benefit from a new…
ASCO ASCO 2025: Experimental Drug Development Centre announces the presentation of updated data from the phase 1 study of antibody-drug conjugate EBC-129 June 9, 2025 The Ental Drug Development Centre (EDDC), Singapore’s national platform for drug discovery and development, has…
Cancer Drug News New method of taxol production has the potential to greatly reduce the cost June 1, 2025 Taxol is one of the most commonly prescribed chemotherapy drugs for breast, ovarian, cervical, and…
Cancer Drug News Scientists call into question safety of potential new anticancer treatment June 1, 2025 Scientists have discovered that a promising new anticancer medicine currently in development could be made…
Cancer Drug News Scientific breakthrough: We can now halve the price of costly cancer drug May 25, 2025 Taxol is one of the most commonly prescribed chemotherapy drugs for breast, ovarian, cervical and…
Cancer Drug News Daratumumab may help cancer patients with low physical function to live longer, study finds May 25, 2025 How cancer patients relying on daratumab feel physically before starting the therapy can predict how long…